Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 70, Issue 1, 1996, Pages 33-39

  Paternoster, D M ^a   Stella, A ^a   Simioni, P ^a   Girolami, A ^a   Plebani, M ^b  

^a Clinica di Ostetricia e Ginecologia   (Italy)

^b NONE   (Italy)

Author keywords

antithrombin; chronic hypertension; fibronectin; pre eclampsia; pregnancy

Indexed keywords

ANTITHROMBIN; BIOCHEMICAL MARKER; FIBRONECTIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FETUS; HUMAN; HYPERTENSION; PATIENT MONITORING; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0030469430     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(96)02550-X     Document Type: Article

References (20)

1. [1] Romero R, Lockwood C, Oyarzun E, Hobbins JC. Toxemia: new concepts in an old disease. Semin Perinatol 1988; 12: 302-323.
2. [2] Zeeman GG, Dekker GH. Pathogenesis of pre-eclampsia. A hypothesis. Clin Obstet Gynecol 1992; 35: 317-337.
3. [3] Leduc L, Wheeler JM, Kirshon B, Mitchell P, Cotton DB. Coagulation profile in severe pre-eclampsia. Obstet Gynecol 1992; 79: 14-18.
4. [4] Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989: 161: 1200-1204.
5. [5] Taylor RN, Casal DC, Lynn AJ, Varma M, Martin JN, Roberts JM. Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression. Am J Obstet Gynecol 1991; 165: 1705-1710.
6. [6] Friedman SA, Taylor RN, Roberts JM. Pathophysiology of pre-eclampsia. Clin Perinatol 1991; 18: 661-682.
7. [7] Dekker GA. Prediction of pregnancy-induced hypertensive disease. Eur J Obstet Gynecol Reprod Biol 1991; 42(suppl): 836-844.
8. [8] Bellegeer V, Spitz B, Kieckens L, Moreau H, van Assche A, Collen D. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 1989; 161: 432-436.
9. [9] National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163: 1689-1712.
10. [10] Lockwood CJ, Peters JH. Increased plasma levels of ED + cellular fibronectin precedes the clinical signs of pre-eclampsia. Am J Obstet Gynecol 1990; 162: 358-362.
11. [11] Shanklin DR, Sibai BM. Ultrastructural aspects of pre-eclampsia: I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 1989; 161: 735-741.
12. [12] De Boer K, Ten Gate JW, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95-100.
13. [13] Gerbasi FR, Bottoms SF, Farag MA, Mammen EF, Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990; 75: 385-389.
14. [14] Saleh AA, Bottoms SF, Farag MA, Dombrowski MP, Welch RA, Norman GS, Mammen EF. Markers for endothelial injury, clotting and platelet activation in pre-eclampsia. Arch Gynecol Obstet 1991; 251: 105-110.
15. [15] Leiberman JR, Hagay ZJ, Mazor M, Wiznitzer A, Aharon M, Nathan I, Dvilansky A. Plasma antithrombin III levels in pre-eclampsia and chronic hypertension. Int J Gynecol Obstet 1988; 27: 21-24.
16. [16] Kobayashi K, Terao T. Pre-eclampsia as chronic disseminated intravascular coagulation. Gynecol Obstet Invest 1987; 170-178.
17. [17] Perry KG, Martin JM. Abnormal hemostasis and coagulopathy in pre-eclampsia and eclampsia. Clin Obstet Gynecol 1992; 35: 338-350.
18. [18] Erikson HO, Hansen PK, Brocks V, Janzen BA. Plasma fibronectin concentration in pre-eclampsia. Acta Obstet Gynaecol Scand 1987; 66: 25-28.
19. [19] Mabie WC, Gonzalez A-R, Sibai BM, Amon E. A comparative trial of Labetalol and Hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987; 70: 328-333.
20. [20] Saleh AA, Bottoms FS, Gerbasi FR, Mammen EF. Hemostasis and diagnosis of pre-eclampsia. Thromb Res 1994; 75(2): 163-171.